Q13451 (FKBP5_HUMAN) Homo sapiens (Human)
Peptidyl-prolyl cis-trans isomerase FKBP5 UniProtKBInterProSTRINGInteractive Modelling
457 aa; Sequence (Fasta) ; (Isoform 2)
Models are currently being built for this target protein.
(Depending on server load, it will take approximately 15-30 minutes before the new models are available in SWISS-MODEL Repository)
Please note that SMR updates are performed with default parameters for template selection and quality filters. If you prefer to interactively explore various models build on different templates, please use SWISS-MODEL workspace.
Available Structures
133 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human FKBP51 protein in complex with C-terminal peptide of Human HSP 90-alpha |
Heteromer Q96HX7; | 100 | 3×SO4; | |||
| Cryo-EM structure of Hsp90:FKBP51:p23 closed-state complex |
Heteromer P07900; Q15185; | 100 | 2×ANP; | |||
| Cryo-EM structure of the GR-Hsp90-FKBP51 complex |
Heteromer P04150; P07900; | 100 | 2×ATP; 2×MG; 1×DEX; | |||
| human Hsp90-FKBP51-PINK1 complex |
Heteromer P07900; Q9BXM7; | 100 | 2×ADP; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low … |
Heteromer P42345; | 100 | 1×RAP; 11×SO4; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR |
Heteromer P42345; | 100 | 1×RAP; | |||
| SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC |
Heteromer P40337; Q15369; Q15370; | 98.33 | 1×XZW; | |||
| The Fk1 domain of FKBP51 in complex with (2S)-2-((1S,5R,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo… | homo-2-mer | 99.2 | 2×RR5; | |||
| Human FKBP5 protein | monomer | 100 | 3×SO4; | |||
| Structure of the Large FKBP-like Protein, FKBP51, Involved in Steroid Receptor Complexes | monomer | 99.72 | 3×SO4; | |||
| Crystal structure of a fragment of FKBP51 comprising the Fk1 and Fk2 domains | monomer | 100 | ||||
| Fk1 domain of FKBP51, crystal form VI | monomer | 100 | ||||
| The Fk1 domain of FKBP51 in complex with Antascomicine B | monomer | 99.2 | 1×Y6Z; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet… | monomer | 99.2 | 1×RSB; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form IV, in presence of DMSO | monomer | 99.2 | 2×DMS; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDE | monomer | 99.2 | 1×CL; 2×NA; 2×NCA; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p… | monomer | 97.6 | 1×UUI; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-5-(hydroxymet… | monomer | 99.2 | 1×9QN; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form IV | monomer | 99.2 | ||||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridi… | monomer | 97.6 | 1×UT6; | |||
| Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52: Complex … | monomer | 99.2 | 1×0OS; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KZ; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxye… | monomer | 99.2 | 1×384; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PYRIDONE | monomer | 99.2 | 1×CL; 2×NA; 2×HRZ; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×0MC; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KU; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dim… | monomer | 99.2 | 1×3JP; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 4-METHYLIMIDAZOLE | monomer | 99.2 | 2×NA; 1×4MZ; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet… | monomer | 99.2 | 1×RQW; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with SAFit1 | monomer | 96.8 | 1×GY1; 1×EPE; 2×GOL; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)… | monomer | 99.2 | 1×0MD; | |||
| Complex of Fk506 with the Fk1 domain mutant A19T of FKBP51 | monomer | 99.2 | 1×FK5; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((R)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p… | monomer | 97.6 | 1×UUI; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with (2R,5S,12R)-12-cyclohexyl-2-… | monomer | 96.8 | 1×S8N; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PIPERIDONE | monomer | 99.2 | 1×CL; 2×NA; 2×V1L; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 63 | monomer | 97.6 | 1×T5H; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×JFK; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form III | monomer | 99.2 | 1×SCN; | |||
| The Fk1 domain of FKBP51 in complex with (2'R,5'S,12'R)-12'-cyclohexyl-2'-[2-(3,4-dimethoxyphenyl)e… | monomer | 99.2 | 1×RTT; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KY; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLE | monomer | 99.2 | 1×CL; 2×NA; 1×IMD; | |||
| The Fk1 domain of FKBP51 in complex with iFit4 | monomer | 99.2 | 1×37K; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form I | monomer | 99.2 | 1×1PE; | |||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand 2-(3-((R)-1-((S)-1-((S)-2-cyclohe… | monomer | 99.2 | 1×5BG; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit DFPFV | monomer | 99.2 | ||||
| The Fk1 domain of FKBP51 in complex with SAFit1 | monomer | 97.6 | 1×GY1; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12h/p | monomer | 97.6 | 1×A1INQ; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 64a | monomer | 97.6 | 1×T5B; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12h/k | monomer | 97.56 | 1×A1INS; | |||
| The Fk1 domain of FKBP51 in complex with iFit1 | monomer | 99.2 | 1×37L; 1×GOL; 1×NA; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH HYDANTOIN | monomer | 99.2 | 1×HYN; 2×NA; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 35-(E) | monomer | 97.6 | 1×T58; 3×IS8; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×0MC; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(11,6)-(E)-OH | monomer | 97.6 | 1×A1IOF; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×I63; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12g/j | monomer | 97.6 | 1×A1INZ; 1×EDO; | |||
| FKBP51FK1 F67E/K60Orn (i, i+7) in complex with SAFit1 | monomer | 94.4 | 1×GY1; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/i | monomer | 97.6 | 1×A1INM; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)propanoy… | monomer | 97.6 | 1×UCT; | |||
| FKBP51FK1 F67E/K58 (i, i+9) in complex with SAFit1 | monomer | 95.2 | 1×GY1; | |||
| Fk1 domain of FKBP51, crystal form VII | monomer | 100 | 1×CO3; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(11,8)-(E)-OH | monomer | 97.6 | 1×A1IOD; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/n | monomer | 97.6 | 1×A1INU; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(11,5)-(E)-OH | monomer | 97.56 | 1×A1IOE; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/l | monomer | 97.6 | 1×A1INT; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-(5-chlorothiophen-2-yl)-2-cyclohe… | monomer | 97.6 | 1×U83; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-cyclohexyl-2-(thiophen-2-yl)acety… | monomer | 97.6 | 1×U8C; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12f/j | monomer | 97.6 | 1×A1INW; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/j | monomer | 97.6 | 1×A1INK; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12h/m | monomer | 97.6 | 1×A1INP; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(2,3)-(E) | monomer | 97.6 | 1×A1IOC; | |||
| Fk1 domain of FKBP51, crystal form II | monomer | 100 | ||||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 11c/i | monomer | 97.6 | 1×A1INL; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 11b/j | monomer | 97.6 | 1×A1INN; | |||
| Evaluation of Synthetic FK506 Analogs as Ligands for the FK506-Binding Proteins 51 and 52: Complex … | monomer | 99.2 | 1×0MD; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12f/l | monomer | 97.6 | 1×A1INX; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12f/o | monomer | 97.56 | 1×A1INY; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15i | monomer | 97.6 | 1×A1H7C; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 33-(Z) | monomer | 97.6 | 1×R3E; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(1,2)-H2 | monomer | 97.6 | 1×A1IN4; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/p | monomer | 97.6 | 1×A1INV; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,2)-Diol-IV | monomer | 97.56 | 1×A1IN7; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23a | monomer | 97.6 | 1×A1H68; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)pent-4-e… | monomer | 97.6 | 1×UC0; | |||
| Fk1 domain of FKBP51, crystal form I | monomer | 100 | ||||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(10,7)-(E)-OH | monomer | 97.6 | 1×A1IOG; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/k | monomer | 97.56 | 1×A1INR; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,2)-(Z) | monomer | 97.6 | 1×A1IN3; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,1)-Diol-II | monomer | 97.6 | 1×A1IN8; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 24e | monomer | 97.6 | 1×A1H7E; | |||
| The Fk1 domain of FKBP51 in complex with (S)-(R)-3-(3,4-dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)p… | monomer | 99.2 | 1×L2Q; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)-2-(3,4,… | monomer | 97.6 | 1×UCO; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog 12c/o | monomer | 97.6 | 1×A1INO; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2 | monomer | 99.2 | 1×37K; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,2)-H2 | monomer | 97.6 | 1×A1IN6; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15b | monomer | 97.6 | 1×A1H7A; | |||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand (1R)-3-(3,4-dimethoxyphenyl)-1-f3… | monomer | 99.2 | 1×5B8; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15h | monomer | 97.6 | 1×A1H7B; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(1,4)-(E) | monomer | 97.6 | 1×A1IN1; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,1)-(E) | monomer | 97.6 | 1×A1IN5; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23b | monomer | 97.52 | 1×A1H7F; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(2,4)-(E) | monomer | 97.6 | 1×A1IOA; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(2,4)-H2 | monomer | 97.6 | 1×A1IOB; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23d | monomer | 97.6 | 1×A1H7D; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(6,4)-(E) | monomer | 97.6 | 1×A1IN9; | |||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]… | monomer | 99.19 | 1×RTQ; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-3,5-dichloro-N-methylphenylsulfonimidoy… | monomer | 97.58 | 1×UMR; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.19 | 1×1KT; 1×DMS; 1×GOL; | |||
| The Fk1 domain of FKBP51 in complex with ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-viny… | monomer | 99.19 | 1×RRZ; | |||
| The FK1 domain of FKBP51 in complex with (3S,11S,11aS)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-v… | monomer | 97.58 | 1×A1H70; | |||
| The FK1 domain of FKBP51 in complex with (3S,11S)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-vinyld… | monomer | 97.58 | 1×A1H78; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with (1S,5S,6R)-10-((3,5-dichloro… | monomer | 96.77 | 1×9QN; | |||
| Complex of the Fk1 domain mutant A19T of FKBP51 with 4-Nitrophenol | monomer | 99.19 | 1×NPO; | |||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12S)-12-(thiophen-2-yl)-2-[2-(3,4-dimethoxyphenyl)e… | monomer | 97.58 | 1×UBK; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit SFPFT | monomer | 99.19 | ||||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)butanoyl… | monomer | 97.5 | 1×UCF; 1×GOL; | |||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]… | monomer | 97.58 | 1×S8N; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit QFPFV | monomer | 99.19 | ||||
| Fk1 domain mutant A19T of FKBP51, crystal form II | monomer | 99.19 | ||||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand (S)-N-(1-carbamoylcyclopentyl)-1-… | monomer | 99.19 | 1×5BH; | |||
| Fk1 domain of FKBP51, crystal form III | monomer | 100 | ||||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(3,1)-(E) | monomer | 97.58 | 1×A1IN2; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(2,2)-(E) | monomer | 97.58 | 1×A1IN3; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 55 | monomer | 97.58 | 1×S5W; | |||
| Fk1 domain of FKBP51, crystal form VIII | monomer | 100 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1R)-1,2-d… | monomer | 99.19 | 1×3JQ; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23j | monomer | 97.54 | 1×A1H7U; | |||
| Allosteric coupling of conformational transitions in the FK1 domain of FKBP51 near the site of ster… | monomer | 99.17 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-d… | monomer | 99.17 | 1×3JR; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23c | monomer | 98.35 | 1×A1H7G; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog p5(1,1)-(E) | monomer | 98.35 | 1×A1IN0; | |||
| The FK1 domain of FKBP51 in complex with the macrocyclic SAFit analog m5(10,8)-(E)-OH | monomer | 98.28 | 1×A1IOH; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 56 | monomer | 98.31 | 1×R3B; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5omp.1.A | monomer | 0.79 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3o5d.1.A | monomer | 0.77 | 95.26 | |||